167 related articles for article (PubMed ID: 35752280)
1. 3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis.
Tizaoui K; Jalouli M; Ouzari HI; Harrath AH; Rizzo R; Boujelbene N; Zidi I
Immunol Lett; 2022 Aug; 248():78-89. PubMed ID: 35752280
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.
Zidi I; Dziri O; Zidi N; Sebai R; Boujelebene N; Ben Hassine A; Ben Yahia H; Laaribi AB; Babay W; Rifi H; Mezlini A; Chelbi H
Immunol Res; 2016 Aug; 64(4):961-8. PubMed ID: 26754763
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
4. New markers for predictions of acute and chronic rejection and graft outcomes in kidney transplant recipients; HLA-G gene 3'UTR 14 bp polymorphism and sHLA-G.
Darbas S; Yilmaz VT; Kocak H; Kisaoglu A; Demiryilmaz I; Aydinli B; Arslan HS; Ucar F
Gene; 2021 Jul; 790():145712. PubMed ID: 33984446
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the
Jiang Y; Lu J; Wu YE; Zhao X; Li L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962267
[TBL] [Abstract][Full Text] [Related]
6. Association of
Kadiam S; Ramasamy T; Ramakrishnan R; Mariakuttikan J
J Clin Pathol; 2020 Aug; 73(8):456-462. PubMed ID: 31796638
[TBL] [Abstract][Full Text] [Related]
7. Association of
Gautam S; Kumar U; Kumar M; Kanga U; Dada R
Immunol Invest; 2020 Feb; 49(1-2):88-105. PubMed ID: 31549885
[No Abstract] [Full Text] [Related]
8. Association between HLA-G 3'UTR 14-bp ins/del polymorphism and susceptibility to breast cancer.
Eskandari-Nasab E; Hashemi M; Hasani SS; Omrani M; Taheri M; Mashhadi MA
Cancer Biomark; 2013; 13(4):253-9. PubMed ID: 24240586
[TBL] [Abstract][Full Text] [Related]
9. The association between functional HLA-G 14bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis.
Ben Fredj N; Sakly K; Bortolotti D; Aissi M; Frih-Ayed M; Rotola A; Caselli E; Cura F; Sakly N; Aouni M; Di Luca D; Rizzo R
Immunol Lett; 2016 Dec; 180():24-30. PubMed ID: 27771469
[TBL] [Abstract][Full Text] [Related]
10. The correlation between soluble human leukocyte antigen (sHLA-G) levels and +3010 polymorphism.
Alyami A; AlJurayyan A; Alosaimi B; Alkadi H; Alkhulaifi F; Al-Jurayb H; Osman A; Christmas S; Alomar S; Al-Bayati Z
Int J Immunogenet; 2024 Feb; 51(1):39-46. PubMed ID: 38087909
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA-G Polymorphisms in the 3'UTR Region and Soluble HLA-G with Kidney Graft Outcome.
Durmanova V; Bandzuchova H; Zilinska Z; Tirpakova J; Kuba D; Buc M; Polakova K
Immunol Invest; 2019 Aug; 48(6):644-658. PubMed ID: 31094243
[No Abstract] [Full Text] [Related]
12. The Impact of
Ouni N; Chaaben AB; Kablouti G; Ayari F; Douik H; Abaza H; Gara S; Elgaaied-Benammar A; Guemira F; Tamouza R
Immunol Invest; 2019 Jul; 48(5):521-532. PubMed ID: 30945586
[TBL] [Abstract][Full Text] [Related]
13.
Gan J; Di XH; Yan ZY; Gao YF; Xu HH
Front Immunol; 2022; 13():1076040. PubMed ID: 36618382
[TBL] [Abstract][Full Text] [Related]
14. High Amounts of Total and Extracellular Vesicle-Derived Soluble HLA-G are Associated with HLA-G 14-bp Deletion Variant in Women with Embryo Implantation Failure.
Nardi Fda S; Slowik R; Michelon T; Manvailer LF; Wagner B; Neumann J; Horn P; Bicalho Mda G; Rebmann V
Am J Reprod Immunol; 2016 Jun; 75(6):661-71. PubMed ID: 26959830
[TBL] [Abstract][Full Text] [Related]
15. Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.
Zidi I; Ben Yahia H; Bortolotti D; Mouelhi L; Laaribi AB; Ayadi S; Zidi N; Houissa F; Debbech R; Boudabous A; Najjar T; Di Luca D; Rizzo R
Int Immunol; 2015 Jun; 27(6):289-96. PubMed ID: 25577194
[TBL] [Abstract][Full Text] [Related]
16. HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients.
Ad'hiah AH; Al-Bayatee NT
Hum Immunol; 2022 Jun; 83(6):521-527. PubMed ID: 35305830
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen (HLA)-G during pregnancy part II: associations between maternal and fetal HLA-G genotypes and soluble HLA-G.
Dahl M; Klitkou L; Christiansen OB; Djurisic S; Piosik ZM; Skovbo P; Møller AM; Steffensen R; Hviid TV
Hum Immunol; 2015 Apr; 76(4):260-71. PubMed ID: 25637667
[TBL] [Abstract][Full Text] [Related]
18. HLA-G 14bp Ins/Del Polymorphism in the 3'UTR Region and Acute Rejection in Kidney Transplant Recipients: An Updated Meta-Analysis.
Kang SW; Oh E; Cho W; Kim M; Park EJ; Kwack KH; Chung K; Nam OH; Chae YK; Ban JY
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684043
[No Abstract] [Full Text] [Related]
19. The relationship of 3'UTR HLA-G14-bp insertion/deletion and +3142 C/G polymorphisms and soluble HLA-G expression with gynecological cancers: An updated meta-analysis.
Tizaoui K; Jalouli M; Boujelbene N; Harrath AH; Ouzari HI; Rizzo R; Zidi I
Immun Inflamm Dis; 2022 Jul; 10(7):e645. PubMed ID: 35759240
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA-G 3'UTR polymorphisms and haplotypes with colorectal cancer susceptibility and prognosis.
Dhouioui S; Laaribi AB; Boujelbene N; Jelassi R; Ben Salah H; Bellali H; Ouzari HI; Mezlini A; Zemni I; Chelbi H; Zidi I
Hum Immunol; 2022 Jan; 83(1):39-46. PubMed ID: 34763955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]